Organization · Venture Capital
Enso Ventures
Enso Ventures is a venture capital firm based in London and New York, specializing in early-stage equity investments in advanced materials and biotechnology. The firm aims to transform markets for a more sustainable future.
Overview
What Enso Ventures does
What Enso Ventures is
Enso Ventures is a venture capital firm based in London and New York, specializing in early-stage equity investments in advanced materials and biotechnology. The firm aims to transform markets for a more sustainable future.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2010
- Approximate age
- About 16 years
- Structured capabilities
- Funder
- Last reviewed
- March 30, 2026
Official channels
Find Enso Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Enso Ventures as a funder
Investment thesis
Enso Ventures focuses on transforming markets for a more sustainable future through early-stage equity investments in advanced materials and biotechnology.
Focus narrative
Enso Ventures invests in early-stage companies valued between $5M and $10M, focusing on sectors that include advanced materials and biotechnology. The firm is particularly interested in investment themes such as revolutionary therapeutics and innovations in battery materials for electric vehicles.
Value beyond capital
Enso Ventures adds value to its portfolio companies by leveraging its expertise in advanced materials and biotechnology, providing strategic guidance, and facilitating connections within the industry to enhance growth and innovation.
Terms and economics
- Typical check
- $5,000,000–$10,000,000
Focus and fit
- Stages
- Seed · Series A · Series B
- Sectors
- Biotech · Advanced Materials
- Regions
- EuropeNorth America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 17
- Recorded notable exits
- Cellectar Biosciences, NeuroVia, and Seres Health
Portfolio context
Notable portfolio companies include Cellectar Biosciences, which focuses on oncology; NeuroVia, specializing in neuro-related therapies; and Seres Health, which works on microbiome solutions. Enso Ventures has made over 15 investments and achieved 7 exits, demonstrating a strong track record in the deep-tech sector.
Common questions
What to know about Enso Ventures
Upseed classifies Enso Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.